https://www.selleckchem.com/pr....oducts/fasoracetam-n
To evaluate whether intrauterine growth restriction (IUGR) adds further neurodevelopmental risk to that posed by very preterm birth alone in terms of alterations in brain growth and poorer toddlerhood outcomes. Participants were 314 infants of very preterm birthenrolled in the Evaluation of Preterm Imaging Study (e-Prime) who were subsequently followed up in toddlerhood. IUGR was identified postnatally from discharge records (n=49) and defined according to prenatal evaluation of growth restriction confirmed by birth weight &l